People · Operator
Named in public records as an officer, director or promoter · active 2015–2015 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| IASO BioMed, Inc. | — | Biotechnology | Pre-Seed | $400K | $5.5M | 2015 |
Richard M Schell at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Richard M Schell on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Karatzas C. Costas | 1 | 1 |
| Duane C. Knight | 1 | 1 |
| Vassilios C. Papadopoulos | 1 | 1 |
| Keith C. Mazer | 1 | 1 |
| Henry C. Fong | 1 | 1 |
| Duane Knight | 1 | 1 |
| Keith Mazer | 1 | 1 |
| Richard Schell | 1 | 1 |
| Costas Kartzas | 1 | 1 |
| Vasillios Papaodpoulos | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.